Search research articles
Contact Us
Filters
Showing results (151-160 of 159) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 159 results.
Nutrients
|
July 27, 2022
Pharmacological and Non-Pharmacological Agents versus Bovine Colostrum Supplementation for the Management of Bone Health Using an Osteoporosis-Induced Rat Model
Eirini K Kydonaki, Laura Freitas, Henrique Reguengo, et al.
European Urology
|
July 6, 2023
Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695)
Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, et al.
British Journal of Pharmacology
|
August 14, 2018
Opposing roles of CB<sub>1</sub> and CB<sub>2</sub> cannabinoid receptors in the stimulant and rewarding effects of cocaine
Pedro H Gobira, Ana C Oliveira, Julia S Gomes, et al.
Nutrients
|
September 28, 2021
Bovine Colostrum Supplementation Improves Bone Metabolism in an Osteoporosis-Induced Animal Model
Eirini K Kydonaki, Laura Freitas, Bruno M Fonseca, et al.
Cancer Research Communications
|
March 29, 2024
First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors
Mark Yarchoan, John D Powderly, Bruno R Bastos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2011
Phase I studies of CBP501, a G2 checkpoint abrogator, as monotherapy and in combination with cisplatin in patients with advanced solid tumors
Geoffrey I Shapiro, Raoul Tibes, Michael S Gordon, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 3, 2018
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer
David E Gerber, Mark A Socinski, Joel W Neal, et al.
Cancer Research Communications
|
May 6, 2024
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies
Carly D Miller, John R Lozada, Nicholas A Zorko, et al.
Science (New York, N.Y.)
|
November 10, 2018
Early human dispersals within the Americas
J Víctor Moreno-Mayar, Lasse Vinner, Peter de Barros Damgaard, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 159) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 159 results.
Nutrients
|
July 27, 2022
Pharmacological and Non-Pharmacological Agents versus Bovine Colostrum Supplementation for the Management of Bone Health Using an Osteoporosis-Induced Rat Model
Eirini K Kydonaki, Laura Freitas, Henrique Reguengo, et al.
European Urology
|
July 6, 2023
Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695)
Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, et al.
British Journal of Pharmacology
|
August 14, 2018
Opposing roles of CB<sub>1</sub> and CB<sub>2</sub> cannabinoid receptors in the stimulant and rewarding effects of cocaine
Pedro H Gobira, Ana C Oliveira, Julia S Gomes, et al.
Nutrients
|
September 28, 2021
Bovine Colostrum Supplementation Improves Bone Metabolism in an Osteoporosis-Induced Animal Model
Eirini K Kydonaki, Laura Freitas, Bruno M Fonseca, et al.
Cancer Research Communications
|
March 29, 2024
First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors
Mark Yarchoan, John D Powderly, Bruno R Bastos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2011
Phase I studies of CBP501, a G2 checkpoint abrogator, as monotherapy and in combination with cisplatin in patients with advanced solid tumors
Geoffrey I Shapiro, Raoul Tibes, Michael S Gordon, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 3, 2018
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer
David E Gerber, Mark A Socinski, Joel W Neal, et al.
Cancer Research Communications
|
May 6, 2024
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies
Carly D Miller, John R Lozada, Nicholas A Zorko, et al.
Science (New York, N.Y.)
|
November 10, 2018
Early human dispersals within the Americas
J Víctor Moreno-Mayar, Lasse Vinner, Peter de Barros Damgaard, et al.
Page
of 16